Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record with results posted

Phase 2 Study of the Safety and Efficacy of an Oral Formulation of SPI-1005 for Prevention of Temporary Auditory Threshold Shift

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01444846
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-06-04T12:58:48.513574+00:00
Published At
2026-06-03T00:00:00+00:00
Record Updated At
2026-06-03
Results Posted At
2026-06-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Temporary Auditory Threshold Shift"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-06-03"
protocolSection.identificationModule.nctId
"NCT01444846"
protocolSection.identificationModule.officialTitle
"Phase 2 Study of the Safety and Efficacy of an Oral Formulation of SPI-1005 for Prevention of Temporary Auditory Threshold Shift"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2026-06-03"

Study condition terms

  • Temporary Auditory Threshold Shift (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.